EVERUS CONSTRUCTION GROUP (ECG) Stock Fundamental Analysis
NYSE:ECG - US3004261034 - Common Stock
78.44 USD
-1.87 (-2.33%)
78.44 USD
0 (0%)
Taking everything into account, ECG scores 5 out of 10 in our fundamental rating. ECG was compared to 53 industry peers in the Construction & Engineering industry. ECG is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. ECG is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
ECG had positive earnings in the past year.
ECG had a positive operating cash flow in the past year.
1.2 Ratios
The Return On Assets of ECG (11.19%) is better than 81.13% of its industry peers.
ECG has a better Return On Equity (32.22%) than 81.13% of its industry peers.
ECG has a Return On Invested Capital of 18.93%. This is amongst the best in the industry. ECG outperforms 83.02% of its industry peers.
ECG had an Average Return On Invested Capital over the past 3 years of 19.20%. This is in line with the industry average of 17.21%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.19% | ||
| ROE | 32.22% | ||
| ROIC | 18.93% |
ROA(3y)11.72%
ROA(5y)N/A
ROE(3y)32.38%
ROE(5y)N/A
ROIC(3y)19.2%
ROIC(5y)N/A
1.3 Margins
The Profit Margin of ECG (5.07%) is better than 67.92% of its industry peers.
In the last couple of years the Profit Margin of ECG has declined.
The Operating Margin of ECG (6.83%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of ECG has declined.
ECG's Gross Margin of 11.89% is on the low side compared to the rest of the industry. ECG is outperformed by 62.26% of its industry peers.
In the last couple of years the Gross Margin of ECG has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.83% | ||
| PM (TTM) | 5.07% | ||
| GM | 11.89% |
OM growth 3Y-2.11%
OM growth 5YN/A
PM growth 3Y-1.91%
PM growth 5YN/A
GM growth 3Y-0.48%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ECG is creating value.
Compared to 1 year ago, ECG has about the same amount of shares outstanding.
ECG has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 5.92 indicates that ECG is not in any danger for bankruptcy at the moment.
ECG has a Altman-Z score of 5.92. This is amongst the best in the industry. ECG outperforms 83.02% of its industry peers.
ECG has a debt to FCF ratio of 2.24. This is a good value and a sign of high solvency as ECG would need 2.24 years to pay back of all of its debts.
ECG has a Debt to FCF ratio of 2.24. This is in the better half of the industry: ECG outperforms 71.70% of its industry peers.
A Debt/Equity ratio of 0.53 indicates that ECG is somewhat dependend on debt financing.
ECG has a Debt to Equity ratio (0.53) which is in line with its industry peers.
Even though the debt/equity ratio score it not favorable for ECG, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 2.24 | ||
| Altman-Z | 5.92 |
ROIC/WACC1.83
WACC10.34%
2.3 Liquidity
A Current Ratio of 1.77 indicates that ECG should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.77, ECG belongs to the top of the industry, outperforming 83.02% of the companies in the same industry.
ECG has a Quick Ratio of 1.69. This is a normal value and indicates that ECG is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.69, ECG belongs to the top of the industry, outperforming 86.79% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.77 | ||
| Quick Ratio | 1.69 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 4.30% over the past year.
Measured over the past years, ECG shows a quite strong growth in Earnings Per Share. The EPS has been growing by 9.37% on average per year.
ECG shows a decrease in Revenue. In the last year, the revenue decreased by -0.16%.
ECG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.57% yearly.
EPS 1Y (TTM)4.3%
EPS 3Y9.37%
EPS 5YN/A
EPS Q2Q%35.26%
Revenue 1Y (TTM)-0.16%
Revenue growth 3Y11.57%
Revenue growth 5YN/A
Sales Q2Q%31.01%
3.2 Future
ECG is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.77% yearly.
ECG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.08% yearly.
EPS Next Y5.17%
EPS Next 2Y7.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year18.88%
Revenue Next 2Y13.08%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
ECG is valuated rather expensively with a Price/Earnings ratio of 24.21.
Based on the Price/Earnings ratio, ECG is valued a bit cheaper than the industry average as 69.81% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of ECG to the average of the S&P500 Index (27.13), we can say ECG is valued inline with the index average.
ECG is valuated rather expensively with a Price/Forward Earnings ratio of 23.95.
ECG's Price/Forward Earnings ratio is in line with the industry average.
ECG is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.76, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.21 | ||
| Fwd PE | 23.95 |
4.2 Price Multiples
ECG's Enterprise Value to EBITDA is on the same level as the industry average.
ECG's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 31.09 | ||
| EV/EBITDA | 16.8 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)4.69
PEG (5Y)N/A
EPS Next 2Y7.77%
EPS Next 3YN/A
5. Dividend
5.1 Amount
ECG does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
78.44
-1.87 (-2.33%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)
Earnings (Next)
Inst Owners84.11%
Inst Owner Change3.63%
Ins Owners0.3%
Ins Owner Change15.22%
Market Cap4.00B
Analysts80
Price Target84.32 (7.5%)
Short Float %2.38%
Short Ratio2.4
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)69.08%
Min EPS beat(2)65.4%
Max EPS beat(2)72.75%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)22.28%
Min Revenue beat(2)21.01%
Max Revenue beat(2)23.55%
Revenue beat(4)4
Avg Revenue beat(4)14.87%
Min Revenue beat(4)3.5%
Max Revenue beat(4)23.55%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)17.54%
PT rev (3m)43.35%
EPS NQ rev (1m)0.82%
EPS NQ rev (3m)-14.76%
EPS NY rev (1m)16.44%
EPS NY rev (3m)18.22%
Revenue NQ rev (1m)6.77%
Revenue NQ rev (3m)2.25%
Revenue NY rev (1m)6.11%
Revenue NY rev (3m)7.45%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.21 | ||
| Fwd PE | 23.95 | ||
| P/S | 1.22 | ||
| P/FCF | 31.09 | ||
| P/OCF | 20.83 | ||
| P/B | 7.78 | ||
| P/tB | 10.78 | ||
| EV/EBITDA | 16.8 |
EPS(TTM)3.24
EY4.13%
EPS(NY)3.28
Fwd EY4.18%
FCF(TTM)2.52
FCFY3.22%
OCF(TTM)3.77
OCFY4.8%
SpS64.08
BVpS10.08
TBVpS7.28
PEG (NY)4.69
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.19% | ||
| ROE | 32.22% | ||
| ROCE | 25.74% | ||
| ROIC | 18.93% | ||
| ROICexc | 20.98% | ||
| ROICexgc | 25.69% | ||
| OM | 6.83% | ||
| PM (TTM) | 5.07% | ||
| GM | 11.89% | ||
| FCFM | 3.94% |
ROA(3y)11.72%
ROA(5y)N/A
ROE(3y)32.38%
ROE(5y)N/A
ROIC(3y)19.2%
ROIC(5y)N/A
ROICexc(3y)19.99%
ROICexc(5y)N/A
ROICexgc(3y)25.54%
ROICexgc(5y)N/A
ROCE(3y)26.11%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.11%
OM growth 5YN/A
PM growth 3Y-1.91%
PM growth 5YN/A
GM growth 3Y-0.48%
GM growth 5YN/A
F-Score5
Asset Turnover2.21
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 2.24 | ||
| Debt/EBITDA | 1.09 | ||
| Cap/Depr | 233.76% | ||
| Cap/Sales | 1.94% | ||
| Interest Coverage | 11.61 | ||
| Cash Conversion | 76.74% | ||
| Profit Quality | 77.65% | ||
| Current Ratio | 1.77 | ||
| Quick Ratio | 1.69 | ||
| Altman-Z | 5.92 |
F-Score5
WACC10.34%
ROIC/WACC1.83
Cap/Depr(3y)170.58%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.42%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.3%
EPS 3Y9.37%
EPS 5YN/A
EPS Q2Q%35.26%
EPS Next Y5.17%
EPS Next 2Y7.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.16%
Revenue growth 3Y11.57%
Revenue growth 5YN/A
Sales Q2Q%31.01%
Revenue Next Year18.88%
Revenue Next 2Y13.08%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-0.33%
EBIT growth 3Y9.22%
EBIT growth 5YN/A
EBIT Next Year18.54%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-15.21%
FCF growth 3Y25.55%
FCF growth 5YN/A
OCF growth 1Y-4.65%
OCF growth 3Y24.12%
OCF growth 5YN/A